| Financial Year |
March 31 2023 |
| Monetary Funds |
333,341,208.15 |
| Held-for-trading Financial Assets |
313,329,991.78 |
| Notes Receivable |
4,019,870.18 |
| Accounts Receivable |
53,563,709.53 |
| Advances to Suppliers |
38,280,452.96 |
| Other Receivables |
560,273.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
177,877,806.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
37,500,831.93 |
| Total Current Assets |
1,231,105,457.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
10,171,749.82 |
| Fixed Assetes |
807,601,106.66 |
| Under-construction Projects |
419,406,184.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
88,271,124.37 |
| R&D expenses |
-- |
| Goodwill |
12,380,478.24 |
| Long-Term Deferred and Prepaid Expenses |
83,619,242.39 |
| Deferred Income Tax Assets |
11,885,385.93 |
| Other Non-Current Assets |
194,787,369.02 |
| Sub-Total of Non-Current Assets |
1,753,920,956.17 |
| Total Assets |
2,985,026,414.03 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
414,357,526.29 |
| Accounts Payable |
316,076,494.71 |
| Accounts Received In Advance |
26,064.85 |
| Employee Compensation Payable |
19,902,906.26 |
| Taxes Payable |
10,138,952.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,153,133.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
6,675,995.52 |
| Sub-Total of Current Liabilities |
808,484,217.05 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
42,244,934.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
70,287,180.71 |
| Total Liabilities |
878,771,397.76 |
| Paid-In Capital(Or Share Stock) |
331,870,000.00 |
| Capital Surplus |
848,653,281.93 |
| Surplus Reserve |
118,475,979.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
790,620,541.69 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,106,255,016.27 |
| Owner's Equity（Stockholder's Equity） |
2,106,255,016.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,985,026,414.03 |
